The characteristics of torasemide - loop diuretic application in patients with compensated heart failure
- Authors: Ovchinnikov A.G1
-
Affiliations:
- Scientific dispensary department of A.L.Myasnikov Institute of Clinical Cardiology, Russian Cardiological Scientific-Industrial Complex of the Ministry of Health of the Russian Federation
- Issue: Vol 17, No 5 (2015)
- Pages: 26-32
- Section: Articles
- URL: https://bakhtiniada.ru/2075-1753/article/view/94278
- ID: 94278
Cite item
Full Text
Abstract
The article deals with the application of loop diuretics in patients with compensated heart failure - the patients without the signs of fluid retention, when diuretics application doesn't seem undoubted as in case of patients with edema syndrome. We discussed the mechanisms of formation of left ventricular filling high pressure in these patients; the possibility of filling pressure correction and, consequently, the improvement of the functional status of patients using loop diuretics; the advantages of using these loop diuretics under such conditions with additional antifibrotic characteristics of torsemide in comparison with other loop diuretics, as well as with thiazide diuretics.
Full Text
##article.viewOnOriginalSite##About the authors
A. G Ovchinnikov
Scientific dispensary department of A.L.Myasnikov Institute of Clinical Cardiology, Russian Cardiological Scientific-Industrial Complex of the Ministry of Health of the Russian Federation
Email: artcardio@mail.ru
д-р мед. наук, Научно-Диспансерный Отдел ИКК им. А.Л.Мясникова ФГБУ РКНПК 121552, Russian Federation, Moscow, ul. 3-ia Cherepkovskaia, d. 15a
References
- Yancy C, Jessup M, Bozkurt B et al. 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 2013; 62: e147.
- Faris R, Flather M, Purcell H et al. Diuretics for heart failure. Cochrane Database Syst Rev 2006; 1: CD003838.
- Pitt B, Zannad F, Remme W.J et al, for the Randomized Aldactone Evaluation Study Investigators. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. N Engl J Med 1999; 341: 709-17.
- Pitt B, Williams G, Remme W et al. The EPHESUS trial: eplerenone in patients with heart failure due to systolic dysfunction complicating acute myocardial infarction. Eplerenone Post-AMI Heart Failure Efficacy and Survival Study. Cardiovasc Drugs Ther 2001; 15: 79-87.
- Meta-Analysis Research Group in Echocardiography (MeRGE) AMI Collaborators. Independent prognostic importance of a restrictive left ventricular filling pattern after myocardial infarction: an individual patient meta - analysis: Meta-Analysis Research Group in Echocardiography acute myocardial infarction. Circulation 2008; 117: 2591-8.
- Opie L, Kaplan N. Diuretics. In: L.Opie, B.Gersh (eds): Drugs for the heart (6th ed). Elsevier Saunders 2005; p. 80-103.
- Азизова А.Г., Овчинников А.Г., Агеев Ф.Т. Сравнительное влияние торасемида и фуросемида на клинический статус и диастолическую функцию левого желудочка у больных с компенсированной сердечной недостаточностью и высоким давлением наполнения левого желудочка. Сердечная недостаточность. 2011; 12: 326-32.
- Yamato M, Sasaki T, Honda К et al. Effects of torasemide on left ventricular function and neurohumoral factors in patients with chronic heart failure. Circ J 2003; 67: 384-90.
- López B, Querejeta R, Gonzalez A et al. Effects of loop diuretics on myocardial fibrosis and collagen type I turnover in chronic heart failure. J Am Coll Cardiol 2004; 43: 2028-35.
- Uchida T, Yamanaga K, Kido H et al. Diuretic and vasodilating actions of torasemide. Cardiology 1994; 84 (Suppl. 2): 14-7.
- Uchida T, Yamanaga K, Nishikawa M et al. Anti - aldosteronergic effect of torasemide. Eur J Pharmacol 1991; 26: 145-50.
- Goodfriend T, Ball D, Oelkers W, Bähr V. Torsemide inhibits aldosterone secretion in vitro. Life Sci 1998; 63: 45-50.
- Cosín J, Díez J. Torasemide in chronic heart failure: results of the TORIC study. Eur J Heart Fail 2002; 4: 507-13.
- Murray M et al. Open - label randomized trial of torsemide compared with furosemide therapy for patients with heart failure. Am J Med 2001; 111: 513-20.
- Lόpez B, González A, Beaumont J et al. Identification of a potential cardiac antifibrotic mechanism of torasemide in patients with chronic heart failure. J Am Coll Cardiol 2007; 50: 859-67.
- Ellison D. Diuretic therapy and resistance in congestive heart failure. Cardiology 2001; 96: 132.
Supplementary files
